← SynDRA
TRELAGLIPTIN
SynDRA canonical compound SYN0026076 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | DPP4 |
|---|
| Mechanism of action | Dipeptidyl peptidase inhibitor |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- Dipeptidyl peptidase inhibitor
- DPP4 inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP2D6
- CYP1A2
- CYP2C19
- CYP2C9
- CYP3A4
- DPP8
- MAPK1
- KCNH2
- HDAC6
- GSK3B
- FGFR2
- ABL1
- AURKA
- CSNK1D
- CDK2
- BRPF1
- BRD4
- TRIM24
Cross-references
Synonyms
- TAK-472
- trelagliptin succinate
- SYR-472
- SYR111472
- zafatek
- Trelagliptine
- Trelagliptina
- SYR 472
- Trelagliptin succinate
- Trelagliptin (succinate)
- UNII-4118932Z90
- AK198895
- 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile
- 4118932Z90
- SYR-472 succinate
- (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile succinate
- SYR 111472 succinate
- Trelagliptin succinate [USAN]
- SYR111472 SUCCINATE
- SYR472
- Zafatek (TN)
- Trelagliptin succinat
- SYR472 succinate
- syr
- trelagliptina
- trelagliptine
- Q836OWG55H
- trelagliptinum
- RefChem:190727
- DTXCID30158169
- Trelagliptin(SYR-472)
- Trelagliptin [USAN]
- MFCD22572746
- C18H20FN5O2
- Trelagliptin (USAN)
- Trelagliptin [USAN:INN]
- UNII-Q836OWG55H
- Trelagliptin(syr472)
Look up TRELAGLIPTIN in the interactive SynDRA portal →